Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.63 USD | -3.16% | -3.28% | +121.03% |
07/05 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
06/05 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+121.03% | 626M | |
+20.65% | 47.02B | |
+49.51% | 41.86B | |
+0.22% | 41.76B | |
-4.27% | 28.8B | |
+11.71% | 26.05B | |
-21.64% | 19.15B | |
+4.33% | 12.55B | |
+28.89% | 12.34B | |
-4.43% | 11.82B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Wedbush Lowers Stoke Therapeutics' Price Target to $25 From $33, Pushes Out STK-001 Launch Timing By 1 Year; Keeps Outperform Rating